Anthrax 2001 – Lessons Learned: Clinical Laboratory and Beyond

Dyan C Luper

doi:10.29074/ascls.15.3.180

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Dyan C Luper⇑
1. is the Senior/Lead Technologist for Microbiology, CHRISTUS Spohn Health System

Address for correspondence: Dyan C Luper, Microbiology Department, CHRISTUS Spohn Hospital Memorial, 2606 Hospital Blvd, Corpus Christi TX 78405. (361) 902-6741, (361) 881-1425 (fax). dyan_luper2{at}iwhs.org

Abstract

OBJECTIVE: Re-visit the 2001 anthrax outbreak to assess the ideas and concepts learned from the event as they relate to the illness and to bioterrorism preparedness.

DATA SOURCES: Current literature.

CONCLUSION: A multitude of lessons have been brought to light. The future of bioterrorism preparedness depends on whether those lessons are acknowledged and acted upon.

ABBREVIATIONS: ASM = American Society for Microbiology; BT = bioterrorism; CDC = Centers for Disease Control; FEMA = Federal Emergency Management Administration; GAO = General Accounting Office; HHS = Health and Human Services; LRN = Laboratory Response Network; NCID/HIP = National Center for Infectious Disease/Hospital Information Program.